Plain-English translation of NCT05064280 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether two medications— and —work better together to treat cancer that has spread to the brain. These medications work in different ways: one helps your immune system fight cancer, while the other slows tumor growth. The study will measure whether the medication combination can shrink brain tumors and how safe it is.
Cancer that spreads to the brain is very difficult to treat, and current options are limited. This trial exists to see if combining these two medications might help more patients with brain metastases and improve their outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive and as ongoing treatment, likely given by injection or by mouth on a regular schedule. You would have frequent visits to the hospital or clinic for blood tests, brain imaging scans (MRI), and check-ups to monitor how the treatment is working and how you are feeling. The study tracks how well the medication shrinks your brain tumors, whether it helps you live longer, and what side effects you experience.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States